Daesung Microbiological Labs. Co., Ltd. (KOSDAQ: 036480)

Daesung Microbiological Labs. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,139	4,362	3,852	4,395	5,212	8,252
Short-Term Investments	5,175	7,365	9,007	5,539	4,840	4,252
Cash & Short-Term Investments	9,315	11,727	12,859	9,935	10,052	12,504
Cash Growth	-18.10%	-8.80%	29.44%	-1.17%	-19.61%	11.90%
Accounts Receivable	3,889	4,131	3,040	2,986	3,675	2,867
Other Receivables	133.19	154.12	155.37	71.96	54.86	103.4
Receivables	4,022	4,285	3,196	3,058	3,730	2,970
Inventory	11,646	12,499	11,641	10,614	9,197	9,266
Prepaid Expenses	111.74	171.07	35.26	32.9	615.23	298.54
Other Current Assets	12.09	34.1	958.97	82.36	163.6	0.64
Total Current Assets	25,107	28,717	28,690	23,722	23,757	25,039
Property, Plant & Equipment	31,274	32,124	33,303	35,846	35,285	23,147
Long-Term Investments	1,690	1,498	1,256	1,327	1,346	950.37
Other Intangible Assets	355.32	356.77	354.83	356.3	358	359.6
Long-Term Deferred Tax Assets	509.45	734.47	134.47	355.46	374.75	463.51
Long-Term Deferred Charges	222.45	330.08	518.86	717.28	846.22	772.46
Other Long-Term Assets	692.4	530.37	852.47	295.71	295.71	295.71
Total Assets	59,851	64,290	65,109	62,620	62,263	51,028
Accounts Payable	2,035	1,543	977.94	768.84	1,237	1,813
Accrued Expenses	488.4	711.53	2,641	2,047	2,180	1,150
Short-Term Debt	3,000	5,319	2,000	700	877.56	700
Current Portion of Long-Term Debt	750	2,125	4,350	1,500	-	-
Current Portion of Leases	231.43	152.28	140.83	175.61	172.18	-
Current Income Taxes Payable	-	-	377.59	-	-	-
Other Current Liabilities	433.93	547.67	124.03	122.82	111.31	106.38
Total Current Liabilities	6,939	10,398	10,611	5,315	4,578	3,769
Long-Term Debt	18,188	16,375	15,500	19,850	20,550	10,500
Long-Term Leases	290.09	40.36	38.45	126.51	302.12	643.11
Other Long-Term Liabilities	-0	127.98	122.51	130.67	-0	-0
Total Liabilities	25,545	26,942	26,272	25,616	25,952	16,312
Common Stock	1,900	1,900	1,900	1,900	1,900	1,900
Additional Paid-In Capital	3,085	3,085	3,085	3,085	3,085	3,085
Retained Earnings	26,161	29,204	30,693	28,859	28,167	26,571
Comprehensive Income & Other	3,160	3,160	3,160	3,160	3,160	3,160
Shareholders' Equity	34,306	37,349	38,837	37,004	36,311	34,715
Total Liabilities & Equity	59,851	64,290	65,109	62,620	62,263	51,028
Total Debt	22,459	24,011	22,029	22,352	21,902	11,843
Net Cash (Debt)	-13,144	-12,284	-9,170	-12,418	-11,850	660.84
Net Cash Growth	-	-	-	-	-	-93.61%
Net Cash Per Share	-3456.15	-3232.58	-2412.16	-3255.27	-3121.22	173.83
Filing Date Shares Outstanding	3.8	3.8	3.8	3.8	3.8	3.8
Total Common Shares Outstanding	3.8	3.8	3.8	3.8	3.8	3.8
Working Capital	18,168	18,319	18,079	18,407	19,179	21,270
Book Value Per Share	9027.97	9828.59	10220.37	9737.79	9555.62	9135.63
Tangible Book Value	33,951	36,992	38,483	36,647	35,953	34,356
Tangible Book Value Per Share	8934.47	9734.70	10127.00	9644.03	9461.40	9041.00
Land	2,982	2,982	2,982	5,335	5,335	5,335
Buildings	16,169	16,596	17,167	17,741	17,791	5,803
Machinery	11,520	9,449	10,679	10,440	11,114	1,049
Construction In Progress	93.25	2,909	2,302	2,038	580.63	10,324

Source: S&P Capital IQ. Standard template. Financial Sources.